Bio-Pharma Marketing
Not only do we offer consulting services, but we also accompany your marketing management to achieve the goals of your medical-marketing and commercialization plans.
Strategic Marketing Consulting
Our multidisciplinary team in Bio-Pharmaceutical Marketing offers specialized consulting services in: Strategic Planning, Feasibility Models, Portfolio Analysis, Product Launch, (Go to Market) Business development, High Specialty Markets, B2B, B2C, B2B2C Models, Deployment, Segmentation, Sizing and Targeting for Sales Forces.
Audience and Market Research
Market research is the basis of our Marketing process, therefore we develop Big Data Health and different modalities of market research; Analysis of audits and portfolios, Audience profiling studies, Opinion surveys, Field studies, Focus groups, Penetration and post-launch studies.
Market Access Consulting
We have a group of experts in Market Access Strategies for both the private and public sector, and high specialty markets.
Through them, we offer practical and targeted advice to achieve highly profitable business objectives.
High Specialty and Hospital Marketing
Marketing in these market segments requires a deep knowledge of the medical specialties and execution of personalized tactics that allow us to advise, update and provide solid clinical evidence based on Evidence Based Medicine.
We design disease marketing strategies and plans specifically directed to High Specialty (Immuno-Oncology, Hemato-Oncology, Rare Diseases, Virology), for the private market of the Health Sector.
How do we achieve this?
We start with a thorough analysis of the market and its opportunities, identifying and segmenting audiences. Then we apply Marketing 4.0 and 5.0, Content Marketing and Omnichannel strategies. We consider aspects such as market access, brand building and the generation of a solid engagement with physicians and patients, all with the clear objective of achieving tangible and lasting results for our clients.
Our services focus on Primary Care, High Specialty Molecules including Immuno-Oncology, Viroimmunology and Orphan Drugs."